Based on the Aveanna Healthcare Holdings Inc stock forecast from 3 analysts, the average analyst target price for Aveanna Healthcare Holdings Inc is USD 4.27 over the next 12 months. Aveanna Healthcare Holdings Inc’s average analyst rating is Hold . Stock Target Advisor’s own stock analysis of Aveanna Healthcare Holdings Inc is Slightly Bearish, which is based on 3 positive signals and 5 negative signals. At the last closing, Aveanna Healthcare Holdings Inc’s stock price was USD 4.42. Aveanna Healthcare Holdings Inc’s stock price has changed by -0.67% over the past week, -22.73% over the past month and +52.94% over the last year.
No recent analyst target price found for Aveanna Healthcare Holdings Inc
No recent average analyst rating found for Aveanna Healthcare Holdings Inc
Company Overview Aveanna Healthcare Holdings Inc
Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers PDN services, which include in-home skilled nursing services to medically fragile children and adults; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and employer of record support and personal care services, as well as in-clinic and home-based therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products, including formulas, supplies, and pumps to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia. Read Less
Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost c...Read More
Frequently Asked Questions About Aveanna Healthcare Holdings Inc (AVAH) Stock
Based on ratings from 3 analysts Aveanna Healthcare Holdings Inc's stock is Hold . Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 1 buy, 1 sell and 1 hold ratings.
Unfortunately we do not have enough data on AVAH's stock to indicate if its a good dividend stock.
Based on targets from 3 analysts, the average taret price for AVAH is USD 4.27 over the next 12 months. The maximum analyst target price is USD 5 while the minimum anlayst target price is USD 2.8.
Unfortunately we do not have enough data on AVAH's stock to indicate if its overvalued.
The last closing price of AVAH's stock was USD 4.42.
The most recent market capitalization for AVAH is USD 1.04B.
Based on targets from 3 analysts, the average taret price for AVAH is projected at USD 4.27 over the next 12 months.
This means that AVAH's stock price may go down by -3.47% over the next 12 months.
We can't find any ETFs which contains Aveanna Healthcare Holdings Inc's stock.
As per our most recent records Aveanna Healthcare Holdings Inc has 33,500 Employees.
Aveanna Healthcare Holdings Inc's registered address is 400 Interstate North Parkway SE, Atlanta, GA, United States, 30339.
You can get more information about it from Aveanna Healthcare Holdings Inc's website at https://www.aveanna.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
What not to like
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Aveanna Healthcare Holdings Inc (AVAH) Stock
Based on ratings from 3 analysts Aveanna Healthcare Holdings Inc's stock is Hold . Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 1 buy, 1 sell and 1 hold ratings.
Unfortunately we do not have enough data on AVAH's stock to indicate if its a good dividend stock.
Based on targets from 3 analysts, the average taret price for AVAH is USD 4.27 over the next 12 months. The maximum analyst target price is USD 5 while the minimum anlayst target price is USD 2.8.
Unfortunately we do not have enough data on AVAH's stock to indicate if its overvalued.
The last closing price of AVAH's stock was USD 4.42.
The most recent market capitalization for AVAH is USD 1.04B.
Based on targets from 3 analysts, the average taret price for AVAH is projected at USD 4.27 over the next 12 months.
This means that AVAH's stock price may go down by -3.47% over the next 12 months.
We can't find any ETFs which contains Aveanna Healthcare Holdings Inc's stock.
As per our most recent records Aveanna Healthcare Holdings Inc has 33,500 Employees.
Aveanna Healthcare Holdings Inc's registered address is 400 Interstate North Parkway SE, Atlanta, GA, United States, 30339.
You can get more information about it from Aveanna Healthcare Holdings Inc's website at https://www.aveanna.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for AVAH !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
